333 related articles for article (PubMed ID: 33181331)
1. Clinical and epidemiological study of cutaneous leishmaniasis in two tertiary care hospitals of Jammu and Kashmir: An emerging disease in North India.
Rather S; Wani M; Shah FY; Bashir S; Yaseen A; Giri FA; Sharma R; Zeerak S; Jabeen Y; Hassan I; Dogra D; Rishi R
Int J Infect Dis; 2021 Feb; 103():138-145. PubMed ID: 33181331
[TBL] [Abstract][Full Text] [Related]
2. A new focus of cutaneous leishmaniasis in Jammu division of Jammu and Kashmir State, India.
Kaul N; Gupta V; Bhardwaj S; Dogra D; Dogra N
Indian J Dermatol Venereol Leprol; 2016; 82(2):145-50. PubMed ID: 26924403
[TBL] [Abstract][Full Text] [Related]
3. Pediatric Cutaneous Leishmaniasis: A Clinico-Epidemiological Study from North India.
Rather S; Yaseen A; Shah FY; Wani M; Krishan K; Zirak S; Sharma R; Hassan I; Dogra D; Rishi R
Indian Dermatol Online J; 2021; 12(6):852-859. PubMed ID: 34934721
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of short-duration (twice weekly) intralesional sodium stibogluconate in treatment of cutaneous Leishmaniasis in India.
Bumb RA; Mehta RD; Ghiya BC; Jakhar R; Prasad N; Soni P; Lezama-Davila C; Satoskar AR
Br J Dermatol; 2010 Oct; 163(4):854-8. PubMed ID: 20500797
[TBL] [Abstract][Full Text] [Related]
5. Intralesional sodium stibogluconate alone or its combination with either intramuscular sodium stibogluconate or oral ketoconazole in the treatment of localized cutaneous leishmaniasis: a comparative study.
El-Sayed M; Anwar AE
J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):335-40. PubMed ID: 19744259
[TBL] [Abstract][Full Text] [Related]
6. Synergistic Effect Of Oral Allopurinol And Intralesional Sodium Stibogluconate In The Treatment Of Cutaneous Leishmaniasis.
Rashid HU; Ullah I; Adeeb H; Zeb M; Mohammad A; Rehman N
J Ayub Med Coll Abbottabad; 2020; 32(4):558-561. PubMed ID: 33225663
[TBL] [Abstract][Full Text] [Related]
7. Randomized, double-blind, controlled, comparative study on intralesional 10% and 15% hypertonic saline versus intralesional sodium stibogluconate in Leishmania donovani cutaneous leishmaniasis.
Ranawaka RR; Weerakoon HS; de Silva SH
Int J Dermatol; 2015; 54(5):555-63. PubMed ID: 25600472
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous leishmaniasis: schedules for intralesional treatment with sodium stibogluconate.
Tallab TM; Bahamdam KA; Mirdad S; Johargi H; Mourad MM; Ibrahim K; el Sherbini AH; Karkashan E; Khare AK; Jamal A
Int J Dermatol; 1996 Aug; 35(8):594-7. PubMed ID: 8854166
[TBL] [Abstract][Full Text] [Related]
9. Long-term efficacy of single-dose radiofrequency-induced heat therapy vs. intralesional antimonials for cutaneous leishmaniasis in India.
Bumb RA; Prasad N; Khandelwal K; Aara N; Mehta RD; Ghiya BC; Salotra P; Wei L; Peters S; Satoskar AR
Br J Dermatol; 2013 May; 168(5):1114-9. PubMed ID: 23298394
[TBL] [Abstract][Full Text] [Related]
10. Comparative efficacy of intralesional sodium stibogluconate (SSG) alone and its combination with intramuscular SSG to treat localized cutaneous leishmaniasis: Results of a pilot study.
Negi AK; Sharma NL; Mahajan VK; Ranjan N; Kanga AK
Indian J Dermatol Venereol Leprol; 2007; 73(4):280. PubMed ID: 17682296
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of intralesional sodium stibogluconate for the treatment of localized cutaneous leishmaniasis at Boru Meda general hospital, Amhara, Ethiopia: Pragmatic trial.
Tilahun Zewdu F; Tessema AM; Zerga AA; van Henten S; Lambert SM
PLoS Negl Trop Dis; 2022 Sep; 16(9):e0010578. PubMed ID: 36084153
[TBL] [Abstract][Full Text] [Related]
12. Meglumine antimoniate is more effective than sodium stibogluconate in the treatment of cutaneous leishmaniasis.
Yesilova Y; Surucu HA; Ardic N; Aksoy M; Yesilova A; Oghumu S; Satoskar AR
J Dermatolog Treat; 2016; 27(1):83-7. PubMed ID: 26105204
[TBL] [Abstract][Full Text] [Related]
13. Treatment of cutaneous leishmaniasis with intralesional sodium stibogluconate.
Solomon M; Baum S; Barzilai A; Pavlotsky F; Trau H; Schwartz E
J Eur Acad Dermatol Venereol; 2009 Oct; 23(10):1189-92. PubMed ID: 19298486
[TBL] [Abstract][Full Text] [Related]
14. Randomized, double-blind, comparative clinical trial on the efficacy and safety of intralesional sodium stibogluconate and intralesional 7% hypertonic sodium chloride against cutaneous leishmaniasis caused by L. donovani.
Ranawaka RR; Weerakoon HS
J Dermatolog Treat; 2010 Sep; 21(5):286-93. PubMed ID: 20438389
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Response to Thermotherapy in Cutaneous Leishmaniasis Treatment Failures for Sodium Stibogluconate: A Randomized Controlled Proof of Principle Clinical Trial.
Silva H; Liyanage A; Deerasinghe T; Sumanasena B; Munidasa D; de Silva H; Weerasingha S; Fernandopulle R; Karunaweera N
Am J Trop Med Hyg; 2021 Jan; 104(3):945-950. PubMed ID: 33534750
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of pentavalent antimoniate intralesional infiltration therapy for cutaneous leishmaniasis: A systematic review.
Brito NC; Rabello A; Cota GF
PLoS One; 2017; 12(9):e0184777. PubMed ID: 28926630
[TBL] [Abstract][Full Text] [Related]
17. Liposomal amphotericin B in comparison to sodium stibogluconate for cutaneous infection due to Leishmania braziliensis.
Solomon M; Baum S; Barzilai A; Scope A; Trau H; Schwartz E
J Am Acad Dermatol; 2007 Apr; 56(4):612-6. PubMed ID: 17276541
[TBL] [Abstract][Full Text] [Related]
18. A comparative controlled trial of intralesionally-administered zinc sulphate, hypertonic sodium chloride and pentavalent antimony compound against acute cutaneous leishmaniasis.
Sharquie KE; Najim RA; Farjou IB
Clin Exp Dermatol; 1997 Jul; 22(4):169-73. PubMed ID: 9499605
[TBL] [Abstract][Full Text] [Related]
19. A new intralesional therapy of cutaneous leishmaniasis with hypertonic sodium chloride solution.
Sharquie KE
J Dermatol; 1995 Oct; 22(10):732-7. PubMed ID: 8586751
[TBL] [Abstract][Full Text] [Related]
20. Clinical and parasite species risk factors for pentavalent antimonial treatment failure in cutaneous leishmaniasis in Peru.
Llanos-Cuentas A; Tulliano G; Araujo-Castillo R; Miranda-Verastegui C; Santamaria-Castrellon G; Ramirez L; Lazo M; De Doncker S; Boelaert M; Robays J; Dujardin JC; Arevalo J; Chappuis F
Clin Infect Dis; 2008 Jan; 46(2):223-31. PubMed ID: 18171254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
